ArticleAdvances in therapy2026

Effectiveness and Safety of Trastuzumab Deruxtecan in Chinese Patients with HER2-Mutant Metastatic Non-Small Cell Lung Cancer (RERUN): Study Protocol for a Real-World, Multicenter, Prospective, Observational Study.

Jianchun Duan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.